Understanding and Addressing Hair Disorders in Transgender Individuals

@article{Gao2018UnderstandingAA,
  title={Understanding and Addressing Hair Disorders in Transgender Individuals},
  author={Yi Gao and Toby A. Maurer and Paradi Mirmirani},
  journal={American Journal of Clinical Dermatology},
  year={2018},
  volume={19},
  pages={517-527}
}
In the United States, an increasing number of individuals are identifying as transgender. Males at birth who identify as females are called male-to-female (MTF) transgender individuals or trans women, and females at birth who identify as males are called female-to-male (FTM) transgender individuals or trans men. The transgender patient population possess unique health concerns disparate from those of the general populace. Exogenous hormone therapy for transgender patients leads to changes in… 
View on Springer
ncbi.nlm.nih.gov
26 Citations
Background Citations
5
Methods Citations
1

26 Citations

Hair loss among transgender and gender‐nonbinary patients: a cross‐sectional study

This cross-sectional study sought to capture the frequency of scalp hair loss and its relation to gender affirming hormone use in gender minority patients.

Dermatologic Conditions in Transgender Populations.

Dermatologic Surgical Care for Transgender Individuals

As dermatologic surgeons have the privilege to improve the health care of transgender patients, they must understand the common and unique concerns of transgender individuals and the role of dermatologic surgeon in their care.

Health considerations for transgender women and remaining unknowns: a narrative review

This narrative review aims to comprehensively summarize health considerations for transgender (trans) women and identify TW-related research areas that will provide answers to remaining unknowns surrounding TW’s health.

Hair removal and psychological well-being in transfeminine adults: associations with gender dysphoria and gender euphoria

Findings cast significant doubt on the assertion that hair removal services for transfeminine people are "cosmetic" and suggest that gender euphoria can be understood in terms of increased subjective well-being associated with gender affirmation, including gender-affirmative medical interventions.

Position statement on the hormonal management of adult transgender and gender diverse individuals

This work aims to provide general practitioners, physicians and other medical professionals with specific Australian recommendations for the hormonal and related management of adult TGD individuals.

Managing Dermatologic Effects of Gender-Affirming Therapy in Transgender Adolescents

Improved understanding of the dermatologic impact of gender-affirming medical care such as pubertal suppression, hormone therapy, and surgeries can enhance patient outcome, and provision of patient-centered gender-Affirming care in dermatologic and multidisciplinary settings is essential.

Laser therapy is a safe and effective treatment for unwanted hair in adults undergoing male to female sex reassignment

Significant reductions in hair growth and significant patient satisfaction are demonstrated, with no AEs, in the transgender transfeminine population at a UK regional laser centre from 2015 to 2020.

An update in facial gender confirming surgery.

Although demand for FGCS is increasing, there remains a need for improving surgical approaches, developing evidence-based care guidelines, and implementing education and awareness in training programs.

Facial Masculinization from Procedures to Payment: A Review.

There are multiple surgical and nonsurgical options to supplement the effect of hormone therapy on facial appearance, including but not limited to: receding the hair line, flattening the forehead, expanding the supraorbital ridge, increasing the dorsal nasal projection, squaring the jaw, and augmenting the chin.

References

SHOWING 1-10 OF 105 REFERENCES

A potential role for the dermatologist in the physical transformation of transgender people: A survey of attitudes and practices within the transgender community.

Reproductive wish in transsexual men.

The data reveal that the majority of transsexual men desire to have children, and more attention should be paid to this topic during the diagnostic phase of transition and to the consequences for genetic parenthood after starting sex reassignment therapy.

Management of transgenderism.

Hormone treatment for both FTM and MTF can be started in early puberty, although long-term effects are not known, and all patients considering treatment need counseling and medical monitoring.

Hormone therapy for transgender patients

  • C. Unger
  • Medicine
    Translational andrology and urology
  • 2016
Many transgender men and women seek hormone therapy as part of the transition process. Exogenous testosterone is used in transgender men to induce virilization and suppress feminizing…

Testosterone therapy for transgender men.

  • M. Irwig
  • Medicine
    The lancet. Diabetes & endocrinology
  • 2017

Female pattern hair loss: Current treatment concepts

While many women using oral antiandrogens and topical minoxidil will regrow some hair, early diagnosis and initiation of treatment is desirable as these treatments are more effective at arresting progression of hair loss than stimulating regrowth.

Current management of male-to-female gender identity disorder in the UK

The clinical features, diagnostic approach and management of male-to-female GID in the UK are reviewed, including the behavioural, psychological and surgical aspects.

Transsexualism: a review of etiology, diagnosis and treatment.

Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience.

Cross-sex hormone treatment of transsexuals seems acceptably safe over the short and medium term, but solid clinical data are lacking.

Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist.

It is concluded that cross-sex hormone treatment of male-to-female transsexuals using GnRHa and oestradiol-17beta valerate is effective, and side effects and complication rates can be reduced using the treatment regimen presented here.
...